Malaria Therapeutic Efficacy Study (TES) Kenya
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Malaria Therapeutic Efficacy Study (TES) Kenya is a clinical trial[1].
Key Facts
- Malaria Therapeutic Efficacy Study (TES) Kenya is in the country of Kenya[2].
- Malaria Therapeutic Efficacy Study (TES) Kenya's instance of is recorded as clinical trial[3].
- Malaria Therapeutic Efficacy Study (TES) Kenya's start time is recorded as +2021-03-15T00:00:00Z[4].
- Malaria Therapeutic Efficacy Study (TES) Kenya's end time is recorded as +2022-08-31T00:00:00Z[5].
- Malaria Therapeutic Efficacy Study (TES) Kenya's main subject is recorded as malaria[6].
- Malaria Therapeutic Efficacy Study (TES) Kenya's number of participants is recorded as {'unit': '1', 'amount': '+400'}[7].
- Malaria Therapeutic Efficacy Study (TES) Kenya's title is recorded as Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Siaya and Bungoma Counties, Kenya[8].
- Malaria Therapeutic Efficacy Study (TES) Kenya's short name is recorded as Kenya-TES[9].
- Malaria Therapeutic Efficacy Study (TES) Kenya's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+6'}[10].
- Malaria Therapeutic Efficacy Study (TES) Kenya's ClinicalTrials.gov ID is recorded as NCT04767191[11].
- Malaria Therapeutic Efficacy Study (TES) Kenya's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+59'}[12].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as lumefantrine[13].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as artemether[14].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as piperaquine[15].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as artemether/lumefantrine[16].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as dihydroartemisinin[17].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as antimalarial[18].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as antiprotozoal[19].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research intervention is recorded as antiparasitic[20].
- Malaria Therapeutic Efficacy Study (TES) Kenya's clinical trial phase is recorded as phase IV clinical trial[21].
- Malaria Therapeutic Efficacy Study (TES) Kenya's research subject recruitment status is recorded as recruiting[22].
- Malaria Therapeutic Efficacy Study (TES) Kenya's study type is recorded as interventional study[23].